# SWOG S1815 (NCT03768414)

> Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

No report yet. It can be ordered.

- Drugs tested: nab-paclitaxel
- Indication: newly diagnosed advanced biliary tract cancers

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03768414
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: SWOG Cancer Research Network
- Conditions: Stage III Distal Bile Duct Cancer AJCC v8; Stage III Gallbladder Cancer AJCC v8; Stage III Intrahepatic Cholangiocarcinoma AJCC v8; Stage IIIA Distal Bile Duct Cancer AJCC v8; Stage IIIA Gallbladder Cancer AJCC v8; Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8; Stage IIIB Distal Bile Duct Cancer AJCC v8; Stage IIIB Gallbladder Cancer AJCC v8; Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Gallbladder Cancer AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Stage IVA Gallbladder Cancer AJCC v8; Stage IVB Gallbladder Cancer AJCC v8; Unresectable Extrahepatic Bile Duct Carcinoma; Unresectable Gallbladder Carcinoma; Unresectable Intrahepatic Cholangiocarcinoma
- Interventions: Cisplatin; Gemcitabine Hydrochloride; Nab-paclitaxel
- Enrollment: 452
- Primary outcome: Overall Survival (OS)

## Indexed commentary on SWOG S1815 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 14
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=swog-s1815-nct03768414

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03768414", "email": "<work email>"}; the inbox owner confirms by the emailed link.